Revive Therapeutics Announces Filing of FDA Pre-IND Meeting

TORONTO, April 03, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV),…

Revive Therapeutics Provides Corporate Update on its COVID-19 and Infectious Diseases Programs

Revive Therapeutics Ltd. (CSE: RVV) TORONTO, March 30, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive”…

Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19

Revive Therapeutics Ltd. (CSE: RVV) TORONTO, March 25, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive”…

Revive Therapeutics Appoints Dr. David Boulware, MD, as Scientific Advisor for Infectious Diseases including COVID-19

Revive Therapeutics Ltd. (CSE: RVV) TORONTO, March 24, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive”…

RVV | A penny stock that may have an Influenza / Covid-19 treatment in its hands ?

For several weeks, the world has been upside down due to the rapid spread of a…

Revive Therapeutics Explores the Use of Bucillamine as a Novel Treatment for Infectious Diseases including COVID-19

TORONTO, March 20, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV),…

Revive Therapeutics Announces Closing of Brokered Private Placement

Revive Therapeutics just release the closing of brokered private placement despite the difficult pandemic conditions :…

Revive Announces Closing of the Acquisition of Psilocin Pharma Corp.

TORONTO, March 05, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”), a company…

Revive Therapeutics | RVV Provides Update on its Clinical Development Plan for Cannabidiol in the Treatment of Autoimmune Hepatitis

TORONTO, Feb. 18, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”), a company…

Revive Enters into Psychedelics Market with Letter of Intent to Acquire Psilocin Pharma Corp.

TORONTO, Feb. 12, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) is pleased…

Revive Therapeutics | RVV to buy truffles from Red Light for psychedelic market

REVIVE THERAPEUTICS TO PURSUE THE PSYCHEDELIC MARKET WITH AGREEMENT AND INVESTMENT IN RED LIGHT HOLLAND FINANCING…

New coverage in cannabis pharma sector with over 1300% upside potential | Revive Therapeutics

Introducing New Featured Stock Pick : Revive Therapeutics Ltd. | RVV The Cannabis Stock is proud to…